Astrazeneca to ‘upgrade’ US listing in latest blow to London Stock Exchange September 29, 2025 Astrazeneca has laid out plans aimed at “upgrading” its US listing in the latest blow to the London Stock Exchange. The Cambridge-based pharma giant said it would replace its existing Nasdaq listing of American Depositary Receipts (ADRs), a type of listing for trading overseas shares, with a direct listing of ordinary shares on the New [...]
Revolut considers $75bn dual listing in London and New York September 28, 2025 Fintech juggernaut Revolut is weighing up a dual listing in New York and London for its share sale, in a move that would provide the City with a major boost after a sluggish IPO period. Revolut considering London as a destination for a listing worth at least $75bn (£55.96bn) would appear to demonstrate a change [...]
Merge London Stock Exchange and Nasdaq to save City market, says fintech boss September 26, 2025 The boss of a UK-born fintech unicorn has called for the London Stock Exchange (LSE) to merge with New York’s Nasdaq in a bid to save the City market’s future prospects. “It’s completely broken,” Barney Hussey-Yeo, founder of AI fintech Cleo, told City AM when asked about the recent string of delistings. Hussey-Yeo, a data [...]
Scrap quarterly reporting for listed companies, Donald Trump says September 15, 2025 President Donald Trump has called for an end to quarterly reporting for US-listed companies in what would be one of the biggest shake-ups to financial markets seen in years. The US president said companies should “no longer be forced” to report results on a quarterly basis and instead report on a six month basis, emulating [...]
Carlyle announce deal with Formula 1 team Red Bull September 9, 2025 Global investment firm Carlyle has announced a multi-year strategic partnership with Formula 1 team Red Bull in a first-of-its-kind deal. The Nasdaq Carlyle Group, with a market cap of $23bn, will use its partnership with the Formula 1 team title sponsored by Oracle to “open new avenues” for engagement, global connectivity and technology. And their [...]
Nvidia stock dips despite record quarter as uncertainty spooks markets August 28, 2025 Nvidia’s earnings once again beat expectations last night, but the AI chipmaker’s shares slipped in after-hours trading due to ongoing uncertainty over China. The Silicon Valley-based group, now worth more than $4tn (£3.1tn) reported fiscal second-quarter revenue of $46.7bn, up 56 per cent year on year, with adjusted earnings per share of $1.05. Both figures came in [...]
My favourite Nasdaq-listed, Chinese-owned, Cayman-incorporated Scottish castle August 22, 2025 A question: what’s the fastest-growing hotel group in Britain? You might opt for Premier Inn, the Whitbred-owned budget chain that’s set to open more than 1,000 new rooms this year. A wildcard choice might be Yotel, the group set up by Yo! Sushi man Simon Woodroffe that’s ballooned from a single site in 2007 to two dozen [...]
Tesla board awards Musk $29bn in shares August 4, 2025 The board of the world’s most valuable carmaker has approved the award of shares to chief executive Elon Musk worth a staggering $29bn (£21.7bn) in efforts to prevent the billionaire from leaving the firm. The new award by Tesla, which amounts to 96 million new shares, comes as part of a new pay deal, after [...]
Pharma stocks suffer as Trump demands prescription slash August 1, 2025 Pharmaceutical stocks across the global markets have taken a hit after Trump demanded drug companies lower prices for American consumers. Trump’s threat against pharmaceuticals has given healthcare sector investors “a dose of the blues” after his letter to various company bosses. It outlined that they should either cut US prescription prices or face a tariff [...]
Could Astrazeneca completely switch its allegiance to the US? July 30, 2025 The UK’s largest listed companies are turning their heads towards the glimmer of the Nasdaq after growing impatient at the lacklustre performance of the London Stock Exchange. Chief among them is pharmaceutical giant Astrazeneca, which cancelled plans for a Liverpool vaccine plant due to lack of economic support earlier this year and has expressed frustration [...]